Business Description
Bio-Path Holdings Inc
NAICS : 325412
SIC : 2834
ISIN : US09057N2018
Description
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.31 | |||||
| Equity-to-Asset | 0.14 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 16.4 | |||||
| 3-Year EPS without NRI Growth Rate | 16.4 | |||||
| 3-Year FCF Growth Rate | 24.9 | |||||
| 3-Year Book Growth Rate | -77.9 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.35 | |||||
| 9-Day RSI | 36.05 | |||||
| 14-Day RSI | 35.64 | |||||
| 6-1 Month Momentum % | -65.17 | |||||
| 12-1 Month Momentum % | -84.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | |||||
| Quick Ratio | 1.6 | |||||
| Cash Ratio | 0.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -39.6 | |||||
| Shareholder Yield % | 2.24 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -256.92 | |||||
| ROA % | -192.15 | |||||
| ROIC % | -781.06 | |||||
| ROC (Joel Greenblatt) % | -781.06 | |||||
| ROCE % | -236.08 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.78 | |||||
| Price-to-Tangible-Book | 3.77 | |||||
| EV-to-EBIT | -0.23 | |||||
| EV-to-EBITDA | -0.24 | |||||
| EV-to-FCF | -0.32 | |||||
| Price-to-Net-Current-Asset-Value | 6.23 | |||||
| Earnings Yield (Greenblatt) % | -434.78 | |||||
| FCF Yield % | -274.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BPTH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bio-Path Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -34.43 | ||
| Beta | -0.45 | ||
| Volatility % | 120.56 | ||
| 14-Day RSI | 35.64 | ||
| 14-Day ATR ($) | 0.893578 | ||
| 20-Day SMA ($) | 3.780885 | ||
| 12-1 Month Momentum % | -84.45 | ||
| 52-Week Range ($) | 2.6 - 44.8 | ||
| Shares Outstanding (Mil) | 1.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bio-Path Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bio-Path Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bio-Path Holdings Inc Frequently Asked Questions
What is Bio-Path Holdings Inc(BPTH)'s stock price today?
The current price of BPTH is $2.68. The 52 week high of BPTH is $44.80 and 52 week low is $2.60.
When is next earnings date of Bio-Path Holdings Inc(BPTH)?
The next earnings date of Bio-Path Holdings Inc(BPTH) is .
Does Bio-Path Holdings Inc(BPTH) pay dividends? If so, how much?
Bio-Path Holdings Inc(BPTH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers